Sergio E. Starkstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sergio E. Starkstein has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
R G Robinson
Department of Psychiatry, University of Iowa, Iowa City, Iowa, USA
9 shared publicationsRicardo Jorge
Department of Psychiatry, University of Iowa, Iowa City, Iowa, USA
9 shared publications- Romina Mizrahi
Clinical and Translational Sciences Lab, Douglas Research Centre, Montreal, Canada
8 shared publications Simone Brockman
School of Psychiatry and Clinical Neurosciences University of Western Australia Crawley W.A Australia
7 shared publications- David G. Bruce
Medical School, University of Western Australia, Fremantle, Australia
5 shared publications Marcelo Merello
Raul Carrea Institute of Neurological Research‐Fleni, Buenos Aires, Argentina
5 shared publications
Latest Publications
- Open Access
- 12 November 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (11) , e112049
Diagnostic Criteria for Depression in Type 2 Diabetes: A Data-Driven Approach
While depression is a frequent psychiatric comorbid condition in diabetes and has significant clinical impact, the syndromal profile of depression and anxiety symptoms has not been examined in detail. To determine the syndromal pattern of the depression and anxiety spectrum in a large series of patients with type 2 diabetes, as determined using a data-driven approach based on latent class analysis (LCA). Type 2 diabetes participants from the observational community-based Fremantle Diabetes Study Phase II underwent assessment of lifetime depression using the Brief Lifetime Depression Scale, the Patient Health Questionnaire 9-item version (PHQ-9) for current depression symptoms, and the Generalized Anxiety Disorder Scale that was specifically developed and validated for this study. The main outcome measure was classes of patients with a specific syndromal profile of depression and anxiety symptoms based on LCA. LCA identified four classes that were interpreted as “major anxious depression”, “minor anxious depression”, “subclinical anxiety”, and “no anxious depression”. All nine DSM-IV/5 diagnostic criteria for major depression identified a class with a high frequency of major depression. All symptoms of anxiety had similar high probabilities as symptoms of depression for the “major depression-anxiety” class. There were significant differences between classes in terms of history of depression and anxiety, use of psychoactive medication, and diabetes-related variables. Patients with type 2 diabetes show specific profiles of depression and anxiety. Anxiety symptoms are an integral part of major depression in type 2 diabetes. The different classes identified here provide empirically validated phenotypes for future research.
- 12 November 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (11) , e112049
Open AccessDiagnostic Criteria for Depression in Type 2 Diabetes: A Data-Driven Approach
While depression is a frequent psychiatric comorbid condition in diabetes and has significant clinical impact, the syndromal profile of depression and anxiety symptoms has not been examined in detail. To determine the syndromal pattern of the depression and anxiety spectrum in a large series of patients with type 2 diabetes, as determined using a data-driven approach based on latent class analysis (LCA). Type 2 diabetes participants from the observational community-based Fremantle Diabetes Study Phase II underwent assessment of lifetime depression using the Brief Lifetime Depression Scale, the Patient Health Questionnaire 9-item version (PHQ-9) for current depression symptoms, and the Generalized Anxiety Disorder Scale that was specifically developed and validated for this study. The main outcome measure was classes of patients with a specific syndromal profile of depression and anxiety symptoms based on LCA. LCA identified four classes that were interpreted as “major anxious depression”, “minor anxious depression”, “subclinical anxiety”, and “no anxious depression”. All nine DSM-IV/5 diagnostic criteria for major depression identified a class with a high frequency of major depression. All symptoms of anxiety had similar high probabilities as symptoms of depression for the “major depression-anxiety” class. There were significant differences between classes in terms of history of depression and anxiety, use of psychoactive medication, and diabetes-related variables. Patients with type 2 diabetes show specific profiles of depression and anxiety. Anxiety symptoms are an integral part of major depression in type 2 diabetes. The different classes identified here provide empirically validated phenotypes for future research.
- 1 February 2012
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 20 (2) , 99-103
The Riddle of Psychiatric Disorders in Parkinson Disease: From Phenomenology to Treatment
- 1 February 2012
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 20 (2) , 99-103
The Riddle of Psychiatric Disorders in Parkinson Disease: From Phenomenology to Treatment
- 11 January 2012
- Published by Wiley in Movement Disorders
- Vol. 27 (2) , 174-178
Apathy in Parkinson's disease: Diagnostic and etiological dilemmas
About one-third of patients with Parkinson's disease (PD) are diagnosed with apathy in cross-sectional studies. However, once patients with concomitant depression and dementia are excluded, the frequency of apathy drops to 5% to 10%. Several scales have been recommended to rate apathy in PD, but specific psychiatric interviews have not been developed, and recently proposed standardized diagnostic criteria are still in the validation process. Most studies assessing the association between subthalamic deep brain stimulation (STN-DBS) and apathy have reported a relative increase in the frequency and severity of apathy, although discrepant findings have also been reported. Several mechanisms to explain apathy in PD have been proposed, from dopaminergic imbalances in frontal-basal ganglia circuits to dysfunction of nondopaminergic circuits and the cingulate gyrus. Future studies should provide reliable and valid instruments to diagnose apathy in PD, and should examine the mechanism of apathy accounting for relevant confounders, such as depression and cognitive deficits, and important contextual factors. Finally, treatment for apathy in PD should not be restricted to psychoactive drugs, but should also include nonpharmacological techniques such as psychotherapy and occupational therapy. © 2012 Movement Disorder Society
- 11 January 2012
- Published by Wiley in Movement Disorders
- Vol. 27 (2) , 174-178
Apathy in Parkinson's disease: Diagnostic and etiological dilemmas
About one-third of patients with Parkinson's disease (PD) are diagnosed with apathy in cross-sectional studies. However, once patients with concomitant depression and dementia are excluded, the frequency of apathy drops to 5% to 10%. Several scales have been recommended to rate apathy in PD, but specific psychiatric interviews have not been developed, and recently proposed standardized diagnostic criteria are still in the validation process. Most studies assessing the association between subthalamic deep brain stimulation (STN-DBS) and apathy have reported a relative increase in the frequency and severity of apathy, although discrepant findings have also been reported. Several mechanisms to explain apathy in PD have been proposed, from dopaminergic imbalances in frontal-basal ganglia circuits to dysfunction of nondopaminergic circuits and the cingulate gyrus. Future studies should provide reliable and valid instruments to diagnose apathy in PD, and should examine the mechanism of apathy accounting for relevant confounders, such as depression and cognitive deficits, and important contextual factors. Finally, treatment for apathy in PD should not be restricted to psychoactive drugs, but should also include nonpharmacological techniques such as psychotherapy and occupational therapy. © 2012 Movement Disorder Society
- Open Access
- 6 January 2012
- Published by S. Karger AG
- Vol. 27, 13-26
Depression, Apathy and Anxiety Disorders
Depression and anxiety disorders are among the most common psychiatric comorbidities in Parkinson’s disease (PD). Most patients will suffer major depression, minor depression or dysthymia at some stage during the progression of the illness. The presence of major depression suggests a more malignant type of PD as it is associated with a faster cognitive and functional decline, and a faster progression along the stages of the illness. Recent studies suggest some antidepressants, and the dopamine agonist pramipexole may be useful to treat depression in PD. Given the paucity of valid instruments to measure anxiety in PD, its frequency and clinical correlates are less well known. Future studies will focus on separating the generic anxiety disorders, such as generalized anxiety disorder and social phobia, from the anxiety symptoms that may be idiosyncratic to the motor symptoms of PD, such as ‘off’ period anxiety. Specific psychotherapeutic techniques are currently being developed to treat depression and anxiety in PD.
- 6 January 2012
- Published by S. Karger AG
- Vol. 27, 13-26
Open AccessDepression, Apathy and Anxiety Disorders
Depression and anxiety disorders are among the most common psychiatric comorbidities in Parkinson’s disease (PD). Most patients will suffer major depression, minor depression or dysthymia at some stage during the progression of the illness. The presence of major depression suggests a more malignant type of PD as it is associated with a faster cognitive and functional decline, and a faster progression along the stages of the illness. Recent studies suggest some antidepressants, and the dopamine agonist pramipexole may be useful to treat depression in PD. Given the paucity of valid instruments to measure anxiety in PD, its frequency and clinical correlates are less well known. Future studies will focus on separating the generic anxiety disorders, such as generalized anxiety disorder and social phobia, from the anxiety symptoms that may be idiosyncratic to the motor symptoms of PD, such as ‘off’ period anxiety. Specific psychotherapeutic techniques are currently being developed to treat depression and anxiety in PD.
- 7 July 2011
- Published by Wiley in Movement Disorders
- Vol. 26 (12) , 2239-2245
Diagnostic criteria for depression in Parkinson's disease: A study of symptom patterns using latent class analysis
Although major depression is one of the most frequent psychiatric disorders among patients with Parkinson's disease, diagnostic criteria have yet to be validated. The main aim of our study was to validate depressive symptoms using latent class analysis for use as diagnostic criteria for major depression in Parkinson's disease. We examined a consecutive series of 259 patients with Parkinson's disease admitted to 2 movement disorders clinics for regular follow‐ups. All patients were assessed with a comprehensive psychiatric interview that included structured assessments for depression, anxiety, and apathy. The main finding was that all 9 Diagnostic and Statistical Manual (4th edition) diagnostic criteria for major depression (ie, depressed mood, diminished interest or pleasure, weight or appetite changes, sleep changes, psychomotor changes, loss of energy, feelings of worthlessness or inappropriate guilt, poor concentration, and suicidal ideation) identified a patient class (severe depression group) with high statistical significance. Latent class analysis also demonstrated a patient class with minimal depressive symptoms (no‐depression group), and a third patient class with intermediate depressive symptoms (moderate depression). Anxiety and apathy were both significant comorbid conditions of moderate and severe depression. Taken together, our findings support the use of the full Diagnostic and Statistical Manual (4th edition) criteria for major depression for use in clinical practice and research in Parkinson's disease and suggest that anxiety may be included as an additional diagnostic criterion. © 2011 Movement Disorder Society
- 7 July 2011
- Published by Wiley in Movement Disorders
- Vol. 26 (12) , 2239-2245
Diagnostic criteria for depression in Parkinson's disease: A study of symptom patterns using latent class analysis
Although major depression is one of the most frequent psychiatric disorders among patients with Parkinson's disease, diagnostic criteria have yet to be validated. The main aim of our study was to validate depressive symptoms using latent class analysis for use as diagnostic criteria for major depression in Parkinson's disease. We examined a consecutive series of 259 patients with Parkinson's disease admitted to 2 movement disorders clinics for regular follow‐ups. All patients were assessed with a comprehensive psychiatric interview that included structured assessments for depression, anxiety, and apathy. The main finding was that all 9 Diagnostic and Statistical Manual (4th edition) diagnostic criteria for major depression (ie, depressed mood, diminished interest or pleasure, weight or appetite changes, sleep changes, psychomotor changes, loss of energy, feelings of worthlessness or inappropriate guilt, poor concentration, and suicidal ideation) identified a patient class (severe depression group) with high statistical significance. Latent class analysis also demonstrated a patient class with minimal depressive symptoms (no‐depression group), and a third patient class with intermediate depressive symptoms (moderate depression). Anxiety and apathy were both significant comorbid conditions of moderate and severe depression. Taken together, our findings support the use of the full Diagnostic and Statistical Manual (4th edition) criteria for major depression for use in clinical practice and research in Parkinson's disease and suggest that anxiety may be included as an additional diagnostic criterion. © 2011 Movement Disorder Society
- 1 June 2011
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 19 (6) , 551-558
Diagnostic Criteria for Depression in Alzheimer Disease: A Study of Symptom Patterns Using Latent Class Analysis
- 1 June 2011
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 19 (6) , 551-558
Diagnostic Criteria for Depression in Alzheimer Disease: A Study of Symptom Patterns Using Latent Class Analysis
- Open Access
- 1 June 2010
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 55 (6) , 355-361
The Frequency, Clinical Correlates, and Mechanism of Anosognosia after Stroke
Objective: To review the frequency, clinical correlates, and mechanism of anosognosia after stroke. Methods: We searched the most recent relevant literature on anosognosia after stroke and carried out a critical analysis of the main findings. Results: Anosognosia is present in about 10% of acute stroke patients and its diagnosis is relatively simple. Nevertheless, a valid and reliable standardization of diagnostic instruments and criteria for research purposes is more difficult to achieve. This limitation may partially account for various instruments available to assess anosognosia and the different strategies used to diagnose this phenomenon. Anosognosia is a fleeting phenomenon and chronic cases are infrequent. There is a robust association between anosognosia and right-hemisphere lesions involving cortical (insular, temporal, and parietal lobes) and subcortical structures (thalamus and basal ganglia). The main clinical correlates of anosognosia are the presence of neglect, cognitive deficits, previous strokes, and older age. Anosognosia has a negative impact on the rehabilitation of stroke patients. The mechanism of anosognosia remains unknown but was explained as owing to psychological denial, disconnexion between left and right hemispheres, and dysfunction of a system that monitors the intention to move and actual movements. Conclusion: Anosognosia is a relatively frequent complication of acute stroke and may become an excellent model to understand the mechanism of human awareness.
- 1 June 2010
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 55 (6) , 355-361
Open AccessThe Frequency, Clinical Correlates, and Mechanism of Anosognosia after Stroke
Objective: To review the frequency, clinical correlates, and mechanism of anosognosia after stroke. Methods: We searched the most recent relevant literature on anosognosia after stroke and carried out a critical analysis of the main findings. Results: Anosognosia is present in about 10% of acute stroke patients and its diagnosis is relatively simple. Nevertheless, a valid and reliable standardization of diagnostic instruments and criteria for research purposes is more difficult to achieve. This limitation may partially account for various instruments available to assess anosognosia and the different strategies used to diagnose this phenomenon. Anosognosia is a fleeting phenomenon and chronic cases are infrequent. There is a robust association between anosognosia and right-hemisphere lesions involving cortical (insular, temporal, and parietal lobes) and subcortical structures (thalamus and basal ganglia). The main clinical correlates of anosognosia are the presence of neglect, cognitive deficits, previous strokes, and older age. Anosognosia has a negative impact on the rehabilitation of stroke patients. The mechanism of anosognosia remains unknown but was explained as owing to psychological denial, disconnexion between left and right hemispheres, and dysfunction of a system that monitors the intention to move and actual movements. Conclusion: Anosognosia is a relatively frequent complication of acute stroke and may become an excellent model to understand the mechanism of human awareness.
- 1 January 2010
- Published by Springer Nature
- p. 199-212
Diagnosis and Clinical Relevance of Depression and Apathy in Alzheimer’s Disease
- 1 January 2010
- Published by Springer Nature
- p. 199-212
Diagnosis and Clinical Relevance of Depression and Apathy in Alzheimer’s Disease
- 15 June 2009
- Published by Wiley in Movement Disorders
- Vol. 24 (8) , 1211-1216
The syndromal validity and nosological position of apathy in Parkinson's disease
Although apathy is among the most frequent behavioral changes in Parkinson's disease (PD), its diagnosis is still problematic, and the overlap with depression and dementia poorly studied. Aim of the study was validate specific criteria to diagnose apathy in PD, and to examine its association with subsyndromes of depression and dementia. A series of 164 patients with PD, 44 patients with “primary” depression and no PD, 23 patients with Alzheimer's disease, and 26 age‐comparable healthy controls underwent a comprehensive psychiatric assessment that included a structured psychiatric interview and the Apathy Scale. A set of seven diagnostic criteria showed high sensitivity and specificity for clinically diagnosed apathy. Fifty‐two of the 164 patients with PD (32%) met diagnostic criteria for apathy. Eighty‐three percent of patients with apathy had comorbid depression and 56% had dementia. Only 5 of the 40 PD patients (13%) with neither depression nor dementia had apathy. We validated a set of standardized criteria for the diagnosis of apathy in PD. About one third of a series of patients attending a Movement Disorders Clinic showed apathy. Both depression and dementia were the most frequent comorbid conditions of apathy in PD. © 2009 Movement Disorder Society
- 15 June 2009
- Published by Wiley in Movement Disorders
- Vol. 24 (8) , 1211-1216
The syndromal validity and nosological position of apathy in Parkinson's disease
Although apathy is among the most frequent behavioral changes in Parkinson's disease (PD), its diagnosis is still problematic, and the overlap with depression and dementia poorly studied. Aim of the study was validate specific criteria to diagnose apathy in PD, and to examine its association with subsyndromes of depression and dementia. A series of 164 patients with PD, 44 patients with “primary” depression and no PD, 23 patients with Alzheimer's disease, and 26 age‐comparable healthy controls underwent a comprehensive psychiatric assessment that included a structured psychiatric interview and the Apathy Scale. A set of seven diagnostic criteria showed high sensitivity and specificity for clinically diagnosed apathy. Fifty‐two of the 164 patients with PD (32%) met diagnostic criteria for apathy. Eighty‐three percent of patients with apathy had comorbid depression and 56% had dementia. Only 5 of the 40 PD patients (13%) with neither depression nor dementia had apathy. We validated a set of standardized criteria for the diagnosis of apathy in PD. About one third of a series of patients attending a Movement Disorders Clinic showed apathy. Both depression and dementia were the most frequent comorbid conditions of apathy in PD. © 2009 Movement Disorder Society
- 1 April 2009
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 17 (4) , 291-298
Apathy Predicts More Severe Parkinsonism in Alzheimer's Disease
- 1 April 2009
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 17 (4) , 291-298
Apathy Predicts More Severe Parkinsonism in Alzheimer's Disease